Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 9,355 | 8,309 | 6,426 | 6,264 | 6,950 |
| Operating Income | -9,355 | -8,309 | -6,426 | -6,264 | -6,950 |
| Other Income | 637 | 667 | 644 | 601 | 175 |
| Pre-tax Income | -8,718 | -7,642 | -5,782 | -5,663 | -6,775 |
| Net Income Continuous | -8,718 | -7,642 | -5,782 | -5,663 | -6,775 |
| Net Income | $-8,718 | $-7,642 | $-5,782 | $-5,663 | $-6,775 |
| EPS Basic Total Ops | -4.60 | -4.00 | 78.80 | -3.00 | -33.10 |
| EPS Basic Continuous Ops | -4.57 | -4.01 | 78.91 | -2.99 | -33.15 |
| EPS Diluted Total Ops | -4.60 | -4.00 | 78.80 | -3.00 | -33.10 |
| EPS Diluted Continuous Ops | -4.57 | -4.01 | 78.91 | -2.99 | -33.15 |
| EBITDA(a) | $-9,366 | $-8,365 | $-6,506 | $-6,251 | $-6,756 |